First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China

International Journal of Antimicrobial Agents

Volumn 32, Issue 3, 2008, Pages 279-281

  Cao, Bin ^a,b   Liu, Yingmei ^a   Song, Shufan ^a   Li, Ran ^a   Wang, Hui ^c   Wang, Chen ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CONFIDENCE INTERVAL; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE AMPLIFICATION; GENOTYPE; LETTER; LOGISTIC REGRESSION ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; CHINA; CROSS INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LENGTH OF STAY; MULTIVARIATE ANALYSIS; RISK FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 49749094008     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.04.005     Document Type: Letter

References (7)

1. Leclercq R., Derlot E., Duval J., and Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319 (1988) 157-161
2. Goossens H., Jabes D., Rossi R., Lammens C., Privitera G., and Courvalin P. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother 51 Suppl. 3 (2003) iii5-12
3. Biedenbach D.J., Bell J.M., Sader H.S., Fritsche T.R., Jones R.N., and Turnidge J.D. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY program report (2003-2004). Int J Antimicrob Agents 30 (2007) 143-149
4. Kim W.J., Weistein R.A., and Hayden M.K. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 7-year period. J Infect Dis 179 (1999) 163-171
5. Thierry N., Nicolas F., Renaud S., Colette S., Antoine D., and Patrice N. First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J Clin Microbiol 43 (2005) 3642-3649
6. Lauderdale T.L., McDonald L.C., Shiau Y.R., Chen P.C., Wang H.Y., Lai J.F., et al. Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother 46 (2002) 525-527
7. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 16 (1995) 105-113